Carlo J. di Fonzo

Director/Miembro de la Junta en Vaneltix Pharma, Inc. .

Health Technology

Consumer Services

Perfil

Carlo J.
di Fonzo is currently a Director at Vaneltix Pharma, Inc. He was previously a Senior VP-Drug Development & Regulatory Affairs at Nektar Therapeutics.
He obtained his undergraduate, graduate, and doctorate degrees from the University of Toronto.

Cargos activos de Carlo J. di Fonzo

Empresas	Cargo	Inicio
Vaneltix Pharma, Inc. Vaneltix Pharma, Inc. Pharmaceuticals: MajorHealth Technology Urigen Pharmaceuticals, Inc. is a specialty pharmaceutical company which focuses on the development and commercialization of innovative products for urology indications. It is specialized in the design and implementation of products for patients with urological ailments, including products for amelioration of bladder pain syndrome and interstitial cystitis. The company was founded in March 1999 and is headquartered in North Brunswick, NJ.	Director/Miembro de la Junta	-

Todos los cargos activos de Carlo J. di Fonzo

Antiguos cargos conocidos de Carlo J. di Fonzo.

Empresas	Cargo	Fin
NEKTAR THERAPEUTICS	Consejero General	-

Ver el detalle de la experiencia de Carlo J. di Fonzo.

Formación de Carlo J. di Fonzo.

University of Toronto

Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Carlo J. di Fonzo.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
NEKTAR THERAPEUTICS	Health Technology

Empresas privadas	1
Vaneltix Pharma, Inc. Vaneltix Pharma, Inc. Pharmaceuticals: MajorHealth Technology Urigen Pharmaceuticals, Inc. is a specialty pharmaceutical company which focuses on the development and commercialization of innovative products for urology indications. It is specialized in the design and implementation of products for patients with urological ailments, including products for amelioration of bladder pain syndrome and interstitial cystitis. The company was founded in March 1999 and is headquartered in North Brunswick, NJ.	Health Technology